The analysis of 67 cases of benign, progressive, tumor CLL, lymph node
lymphocytoma, CLL sarcoma transformation showed that the cases were m
isdiagnosed in 35.8% cases. The most common mistake (25:4%) was aggres
sive chemotherapy based on histological diagnosis of prolymphocytic, p
rolymphocytic-lymphoblastic lymphosarcoma without consideration of cyt
ological and clinical evidence, tumor phenotype. The authors think val
id to use the following criteria in diagnosis of lymphoproliferative d
iseases: histological findings, clinical manifestations and blood pict
ure, tumor cell cytology, primary location and predominant disseminati
on of the tumor, immunophenotype, characteristic chromosomal disorders
, response to treatment.